3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 1/2
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
3
Lung Neoplasms
2
Thymus Neoplasms
1
Small Cell Lung Carcinoma
1
Resected Pancreatic Adenocarcinoma
1
Oropharyngeal Neoplasms
1
Nasopharyngeal Carcinoma
1
Meningioma
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Carcinoma
1
Carcinoid Tumor
1
Adenocarcinoma Of Esophagus
1
Interventions
Cisplatin
35
pembrolizumab
29
Radiotherapy
26
Cetuximab
26
Docetaxel
17
Paclitaxel
13
Fluorouracil
13
Cyclophosphamide
12
fludarabine
11
Radiotherapy, Intensity-Modulated
11
Nivolumab
10
Carboplatin
9
atezolizumab
7
Radiation
7
Gemcitabine
7
Erlotinib Hydrochloride
7
Bortezomib
7
fludarabine phosphate
6
Pemetrexed
5
Interleukin-2
5
Radiosurgery
4
Everolimus
4
Drug Therapy
4
Azacitidine
4
olaparib
3
motexafin gadolinium
3
durvalumab
3
cemiplimab
3
Trastuzumab
3
Irinotecan
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Head and Neck Neoplasms
×
Proton Therapy
×
Clear all
NCT06446713
2025-04-03
PIRATES
University Medical Center Groningen
Phase 1
Recruiting
17 enrolled